BeiGene shareholders re-elect all director nominees and approve share issuance/repurchase mandates at AGM

BeOne Medicines Ltd.

Re-elected directors Hooper (956M for), Krishana (890M for), Wang (987M for), Yi (846M for), Sharp (985M for).
Approved 20% share issuance mandate (718M for, 277M against) and 10% share repurchase mandate (995M for, 99K against).
Approved Connected Person Placing Authorization for Amgen to maintain shareholding for up to 5 years, renewable annually.
Ratified Ernst & Young as independent auditors for FY2025 (989M for, 6M against).
Advisory say-on-pay passed with 875M for, 120M against.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.